Clinical and Experimental Reproductive Medicine

The Korean Society for Reproductive Medicine (대한생식의학회)
권호 표지
DOI QR코드

DOI QR Code

Significance of the serum CA-125 level in intrauterine insemination cycles

  • Choe, Seung-Ah (Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Institute of Reproductive Medicine and Population, Medical Research Center, Seoul National University College of Medicine) ;
  • Ku, Seung-Yup (Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Institute of Reproductive Medicine and Population, Medical Research Center, Seoul National University College of Medicine) ;
  • Jee, Byung-Chul (Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Institute of Reproductive Medicine and Population, Medical Research Center, Seoul National University College of Medicine) ;
  • Suh, Chang-Suk (Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Institute of Reproductive Medicine and Population, Medical Research Center, Seoul National University College of Medicine) ;
  • Kim, Seok-Hyun (Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Institute of Reproductive Medicine and Population, Medical Research Center, Seoul National University College of Medicine) ;
  • Choi, Young-Min (Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Institute of Reproductive Medicine and Population, Medical Research Center, Seoul National University College of Medicine) ;
  • Kim, Jung-Gu (Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Institute of Reproductive Medicine and Population, Medical Research Center, Seoul National University College of Medicine) ;
  • Moon, Shin-Young (Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Institute of Reproductive Medicine and Population, Medical Research Center, Seoul National University College of Medicine)
  • Received : 2010.12.01
  • Accepted : 2011.06.20
  • Published : 2011.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective: There are limited data regarding the significance of elevated serum CA-125 level during IUI cycles, even though it is used widely during the initial evaluation of infertile patients. The aim of this study was to investigate the prognostic value of serum CA-125 levels during IUI cycles. Methods: Among the patients with controlled ovarian stimulation and IUI cycles at Seoul National University Hospital from Jan 2005 through Dec 2009, 92 cases with no identified endometriotic lesion, ovarian tumor, salpingeal lesion, or uterine myoma were selected. To compare the clinical characteristics between the pregnancy group and the non-pregnancy group, the Mann-Whitney U test and Fisher's exact test were used. Results: The overall pregnancy rate was 18.5% (17/92). The pregnancy group showed a higher number of follicles 16 mm in diameter ($p$=0.036), endometrial thickness ($p$ <0.001), ampules of gonadotropin ($p$=0.009), and higher body mass index ($p$=0.022) than the non-pregnancy group. No significant difference was observed in the serum CA-125 level or the proportion of patients with CA-125 exceeding 17 IU/mL between the two groups. Conclusion: The prognostic value of serum CA-125 level among infertile patients with IUI cycles is considered limited.

Keywords

References

  1. Jansen RP. Minimal endometriosis and reduced fecundability: prospective evidence from an artificial insemination by donor program. Fertil Steril 1986;46:141-3. https://doi.org/10.1016/S0015-0282(16)49474-4
  2. Toma SK, Stovall DW, Hammond MG. The effect of laparoscopic ablation or danocrine on pregnancy rates in patients with stage I or II endometriosis undergoing donor insemination. Obstet Gynecol 1992;80:253-6.
  3. Nuojua-Huttunen S, Tomas C, Bloigu R, Tuomivaara L, Martikainen H. Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome. Hum Reprod 1999;14:698-703. https://doi.org/10.1093/humrep/14.3.698
  4. Colacurci N, Fortunato N, De Franciscis P, Fratta M, Cioffi M, Zarcone R, et al. Serum and peritoneal CA-125 levels as diagnostic test for endometriosis. Eur J Obstet Gynecol Reprod Biol 1996;66:41-3. https://doi.org/10.1016/0301-2115(95)02372-0
  5. Medeiros LR, Rosa DD, da Rosa MI, Bozzetti MC. Accuracy of CA 125 in the diagnosis of ovarian tumors: a quantitative systematic review. Eur J Obstet Gynecol Reprod Biol 2009;142:99-105. https://doi.org/10.1016/j.ejogrb.2008.08.011
  6. Mol BW, Bayram N, Lijmer JG, Wiegerinck MA, Bongers MY, van der Veen F, et al. The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis. Fertil Steril 1998;70:1101-8. https://doi.org/10.1016/S0015-0282(98)00355-0
  7. Gurgan T, Kisnisci H, Yarali H, Aksu T, Zeyneloglu H, Develioglu O. Serum and peritoneal fluid CA-125 levels in early stage endometriosis. Gynecol Obstet Invest 1990;30:105-8. https://doi.org/10.1159/000293228
  8. Koninckx PR, Meuleman C, Oosterlynck D, Cornillie FJ. Diagnosis of deep endometriosis by clinical examination during menstruation and plasma CA-125 concentration. Fertil Steril 1996;65:280-7. https://doi.org/10.1016/S0015-0282(16)58086-8
  9. Medl M, Ogris E, Peters-Engl C, Mierau M, Buxbaum P, Leodolter S. Serum levels of the tumour-associated trypsin inhibitor in patients with endometriosis. Br J Obstet Gynaecol 1997;104:78-81. https://doi.org/10.1111/j.1471-0528.1997.tb10653.x
  10. World Health Organization. WHO laboratory manual for the examination of human semen and sperm-cervical mucus interaction. Cambridge: Cambridge University Press; 1999.
  11. Lanzone A, Fulghesu AM, Guida C, Muscatello R, Caruso A, Mancuso S. Serum CA-125 levels do not depend on ovarian steroidogenesis. Fertil Steril 1990;54:415-8. https://doi.org/10.1016/S0015-0282(16)53754-6
  12. Tavmergen E, Sendag F, Goker EN, Levi R. Value of serum CA-125 concentrations as predictors of pregnancy in assisted reproduction cycles. Hum Reprod 2001;16:1129-34. https://doi.org/10.1093/humrep/16.6.1129
  13. Urbancsek J, Hauzman EE, Murber A, Lagarde AR, Rabe T, Papp Z, et al. Serum CA-125 and inhibin B levels in the prediction of ovarian response to gonadotropin stimulation in in vitro fertilization cycles. Gynecol Endocrinol 2005;21:38-44. https://doi.org/10.1080/09513590500099438
  14. Zweers A, De Boever J, Serreyn R, Vandekerckhove D. Correlation between peripheral CA-125 levels and ovarian activity. Fertil Steril 1990;54:409-14. https://doi.org/10.1016/S0015-0282(16)53753-4
  15. Miller KA, Deaton JL, Pittaway DE. Evaluation of serum CA 125 concentrations as predictors of pregnancy with human in vitro fertilization. Fertil Steril 1996;65:1184-9. https://doi.org/10.1016/S0015-0282(16)58336-8
  16. Singh M, Goldberg J, Falcone T, Nelson D, Pasqualotto E, Attaran M, et al. Superovulation and intrauterine insemination in cases of treated mild pelvic disease. J Assist Reprod Genet 2001;18:26-9. https://doi.org/10.1023/A:1026446612485
  17. Werbrouck E, Spiessens C, Meuleman C, D'Hooghe T. No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women with unexplained infertility after controlled ovarian hyperstimulation and intrauterine insemination. Fertil Steril 2006;86:566-71. https://doi.org/10.1016/j.fertnstert.2006.01.044
  18. Surrey ES, Halme J. Endometriosis as a cause of infertility. Obstet Gynecol Clin North Am 1989;16:79-91.
  19. Merviel P, Heraud MH, Grenier N, Lourdel E, Sanguinet P, Copin H. Predictive factors for pregnancy after intrauterine insemination (IUI): an analysis of 1038 cycles and a review of the literature. Fertil Steril 2010;93:79-88. https://doi.org/10.1016/j.fertnstert.2008.09.058
  20. Plosker SM, Jacobson W, Amato P. Predicting and optimizing success in an intra-uterine insemination programme. Hum Reprod 1994;9:2014-21. https://doi.org/10.1093/oxfordjournals.humrep.a138385
  21. Esmailzadeh S, Faramarzi M. Endometrial thickness and pregnancy outcome after intrauterine insemination. Fertil Steril 2007;88:432-7. https://doi.org/10.1016/j.fertnstert.2006.12.010
  22. Wang JX, Warnes GW, Davies MJ, Norman RJ. Overweight infertile patients have a higher fecundity than normal-weight women undergoing controlled ovarian hyperstimulation with intrauterine insemination. Fertil Steril 2004;81:1710-2. https://doi.org/10.1016/j.fertnstert.2003.10.037
  23. Dodson WC, Kunselman AR, Legro RS. Association of obesity with treatment outcomes in ovulatory infertile women undergoing superovulation and intrauterine insemination. Fertil Steril 2006;86:642-6. https://doi.org/10.1016/j.fertnstert.2006.01.040
  24. Crosignani PG, Ragni G, Parazzini F, Wyssling H, Lombroso G, Perotti L. Anthropometric indicators and response to gonadotrophin for ovulation induction. Hum Reprod 1994;9:420-3. https://doi.org/10.1093/oxfordjournals.humrep.a138521
  25. White DM, Polson DW, Kiddy D, Sagle P, Watson H, Gilling-Smith C, et al. Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: an analysis of 109 pregnancies in 225 women. J Clin Endocrinol Metab 1996;81:3821-4. https://doi.org/10.1210/jc.81.11.3821